BD HPV Assay Added to ASCCP Guidelines for Cervical Cancer Screening
BD’s HPV Assay has been added to the ASCCP Risk-Based Management Guidelines, leveraging extended genotyping for enhanced HPV screening.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Cervical (HPV) |
BD’s HPV Assay has been added to the ASCCP Risk-Based Management Guidelines, leveraging extended genotyping for enhanced HPV screening.
Read MorePosted by Andy Lundin | Jan 16, 2025 | Lymphoma |
A new test for Roche received FDA clearance as a sensitive diagnostic tool to differentiate B-cell lymphomas for improved diagnosis.
Read MorePosted by Andy Lundin | Jan 14, 2025 | Compliance |
Xifin’s CEO sees a window of opportunity for lawmakers to modify the Final Rule on LDTs that will be a win-win for the industry and patients.
Read MorePosted by Andy Lundin | Jan 13, 2025 | Dementias & Alzheimer’s |
Declining blood levels of acetyl-L-carnitine and free carnitine are closely linked to Alzheimer’s severity, with sex-specific differences.
Read MorePosted by Andy Lundin | Jan 10, 2025 | Lung Cancer |
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read More